Top Markets
Coin of the day
CytoMed Therapeutics Limited CytoMed Therapeutics Limited

CytoMed Therapeutics Limited

GDTC
Hisse Senetlerindeki Sıralama #32324
CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical... CytoMed Therapeutics Limited is a biopharmaceutical company in the pre-clinical development phase, founded in 2018 and based in Singapore. The firm specializes in creating advanced cellular immunotherapies aimed at combating various human malignancies. Its primary investigational product, CTM-N2D, involves cultivated gamma delta T cells that are engineered with a chimeric antigen receptor (CAR) specifically targeting natural killer group 2D ligands, designed to boost their capacity to destroy cancer cells. Beyond its lead candidate, CytoMed is also advancing iPSC-gdNKT, which utilizes induced pluripotent stem cells (iPSCs) to generate a novel hybrid cell combining properties of both gamma delta T cells and natural killer cells. Additionally, the company is developing CTM-GDT, an immunotherapy consisting of expanded gamma delta T cells that leverages their innate, broad-spectrum recognition system to identify and address diverse cancer types.
Hisse Fiyatı
$0.88
Son senkronizasyon: 2026-08-17
Piyasa Değeri
$10.41M
Değişim (1 gün)
-7.26%
Değişim (1 yıl)
-50.56%
Ülke
SG
Ticaret CytoMed Therapeutics Limited (GDTC)

Kategori

CytoMed Therapeutics Limited (GDTC) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $0.84 - 2026-08-01

Gün sonu en düşük fiyat: $3.48 - 2023-04-01
CytoMed Therapeutics Limited için hisse fiyatı geçmişi: 2023 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) -14.06%
2025 -41.13%
2024 -30.38%
2023 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$515.58 32.24%
US
$992.01 50.00%
NL
$110.14 -37.49%
AU
$736.64 6.99%
CH
$1.06K -7.10%
KR